BIOCEPT INC Quarterly Costs and Expenses in USD from Q3 2014 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Biocept Inc quarterly/annual Costs and Expenses history and growth rate from Q3 2014 to Q2 2023.
Biocept Inc Costs and Expenses for the quarter ending June 30, 2023 was $6.7M, a 57.3% decline year-over-year.
Biocept Inc Costs and Expenses for the twelve months ending June 30, 2023 was $34.5M, a 52.4% decline year-over-year.
Biocept Inc annual Costs and Expenses for 2022 was $57.8M, a 9.14% decline from 2021.
Biocept Inc annual Costs and Expenses for 2021 was $63.7M, a 48.3% increase from 2020.
Biocept Inc annual Costs and Expenses for 2020 was $42.9M, a 50.2% increase from 2019.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2023	$34.5M	$6.7M	-$9.01M	-57.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$43.5M	$7.77M	-$14.3M	-64.8%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$57.8M	$8.88M	-$7.88M	-47%	Oct 1, 2022	Dec 31, 2022	10-K	2023-04-17
Q3 2022	$65.7M	$11.2M	-$6.86M	-38%	Jul 1, 2022	Sep 30, 2022	10-Q/A	2023-04-17
Q2 2022	$72.6M	$15.7M	+$1.91M	+13.9%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	$70.7M	$22.1M	+$7M	+46.4%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-10
Q4 2021	$63.7M	$16.8M	+$206K	+1.25%	Oct 1, 2021	Dec 31, 2021	10-K	2023-04-17
Q3 2021	$63.5M	$18M	+$6.62M	+58%	Jul 1, 2021	Sep 30, 2021	10-Q/A	2023-04-17
Q2 2021	$56.8M	$13.8M	+$6.44M	+87.7%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-11-10
Q1 2021	$50.4M	$15.1M	+$7.46M	+97.8%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-23
Q4 2020	$42.9M	$16.5M	+$9.11M	+123%	Oct 1, 2020	Dec 31, 2020	10-K	2022-04-05
Q3 2020	$33.8M	$11.4M	+$4.25M	+59.3%	Jul 1, 2020	Sep 30, 2020	10-Q/A	2022-02-15
Q2 2020	$29.6M	$7.35M	+$238K	+3.35%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-16
Q1 2020	$29.3M	$7.63M	+$750K	+10.9%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-12
Q4 2019	$28.6M	$7.43M	+$637K	+9.37%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-31
Q3 2019	$27.9M	$7.16M	+$389K	+5.75%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-16
Q2 2019	$27.6M	$7.11M	+$252K	+3.67%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	$27.3M	$6.88M	-$202K	-2.85%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-14
Q4 2018	$27.5M	$6.8M	+$236K	+3.6%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-27
Q3 2018	$27.3M	$6.77M	-$84.8K	-1.24%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-13
Q2 2018	$27.4M	$6.86M	+$106K	+1.56%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-14
Q1 2018	$27.3M	$7.08M	+$1.01M	+16.6%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-14
Q4 2017	$26.2M	$6.56M	+$1.18M	+21.9%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-29
Q3 2017	$25.1M	$6.85M	+$1.18M	+20.8%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14
Q2 2017	$23.9M	$6.76M	+$1.56M	+30%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-14
Q1 2017	$22.3M	$6.07M	+$1.08M	+21.6%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-15
Q4 2016	$21.2M	$5.38M	+$655K	+13.9%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-28
Q3 2016	$20.6M	$5.67M	+$1.15M	+25.4%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-14
Q2 2016	$19.4M	$5.2M	+$1.23M	+30.9%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-14
Q1 2016	$18.2M	$4.99M	+$1.19M	+31.4%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-15
Q4 2015	$17M	$4.73M			Oct 1, 2015	Dec 31, 2015	10-K	2017-03-28
Q3 2015		$4.52M	+$802K	+21.5%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-10
Q2 2015		$3.97M			Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-05
Q1 2015		$3.8M			Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-13
Q3 2014		$3.72M			Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.